Incidence and severity of infections according to the development of neutropenia during combined therapy with pegylated interferon-alpha2a plus ribavirin in chronic hepatitis C infection
Authors:
- A. Juarez-NavarroAJA. Juarez-Navarro
- L. Vera-De-LeonLVL. Vera-De-Leon
- J.M. NavarroJNJ.M. Navarro
- R. Chirino-SprungRCR. Chirino-Sprung
- M. Diaz-HernandezMDM. Diaz-Hernandez
- L. Casillas-DavilaLCL. Casillas-Davila
- M. Dehesa-ViolanteMDM. Dehesa-Violante
- 1 January 2005
- journal article
- Published by Portico in Methods and Findings in Experimental and Clinical Pharmacology
- Vol. 27 (5) , 317-22